# A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

> **NCT02061293** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 95 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Diphenhydramine
- **BEHAVIORAL:** Motivational Enhancement and Taking Action (META)

## Key facts

- **NCT ID:** NCT02061293
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2022-11-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02061293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02061293, "A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02061293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*